Background: Activation of either the 55-kD tumor necrosis factor receptor (TNF-R1) or CD95 (Fas/Apo-1) causes apoptosis of cells and liver failure in mice, and has
INTRODUCTION
The cytokine receptors TNF-R1 (CD121a) and CD95 (Fas[l] , Apo-I [2] ) belong to the nerve growth factor/tumor necrosis factor receptor (TNF-R) familiy (3) . All members of this family share common structural features in their extracellular regions, such as multiple cysteine-rich domains. Their cytoplasmic tails do not display significant homology except for an 80-amino acid motif expressed on TNF-RL, CD95 , and some less well characterized proteins which interact with these two surface receptors (4) .
Since activation of both TNF-R1 and CD95 by natural ligands and agonistic antibodies, respectively, causes apoptosis (5-10) by signaling through this 80-amino acid motif, it has been due to endogenous or exogenous TNF was not affected in animals or liver cell cultures lacking the expression of functional CD95. Conclusions: TNF-R1 and CD95 are independent and differentially regulated triggers of murine apoptotic liver failure.
termed the "death domain" (11) (12) (13) (14) . Indeed, it has recently been shown that its overexpression is sufficient to mediate apoptotic cell death in cultured cell lines (15) .
In addition to the homology between TNF-R1 and CD95 (16) , a highly conserved functional homology seems to exists between their respective ligands, TNF and CD95L (FasL) . Both cytokines are expressed in a membrane bound form that is biologically active (10, 17, 18) , form homotrimers in solution (19, 20) , and can trigger apoptosis in a large variety of target cells including hepatocytes (21, 22) . A possible interaction between the signal transduction pathways that mediate apoptosis following TNF-R1 or CD95 activation has been repeatedly discussed (23) (24) (25) (26) (27) (28) . Several recent in vitro investigations, however, suggested that these two related surface receptors cause cytotoxicity independently of each other with respect to activation kinetics (29) , signal transduction pathways (30, 31) , and susceptibility to pharmacological intervention (32) .
The liver is one of the organs most affected by septic injury due to systemic inflammatory response syndrome (SIRS). It is generally agreed that during the initial stages of SIRS, high circulating levels of TNF contribute to circulatory failure, organ damage, and lethality. In fact, high TNF release represents the final toxic mechanism common to several murine models of SIRS. Direct injection (33) or induction of endogenous TNF by lipopolysaccharide (34) , mitogens (35) (36) (37) , or superantigens (38) (39) (40) causes circulatory shock and liver failure. In these models, antibodies directed against TNF completely prevented liver destruction. TNF-triggered liver cell death appears to occur by apoptosis during the early stages of organ damage and is followed by massive secondary necrosis (21, 41, 42 ).
An alternate mechanism for triggering apoptosis in murine liver involves the activation of CD95. Injection of an agonistic anti-CD95 antibody (anti-CD95) in mice causes lethality and fulminant hemorrhagic liver injury associated with morphological appearance of apoptotic hepatocytes (22) . Moreover, it has recently been demonstrated that CD95 expression is increased in livers of patients suffering from viral infection (43) or fulminant hepatitis (44) . However, from these in vivo studies it is not clear whether activation of CD95 on the surface of liver parenchymal cells leads directly to apoptosis. Alternatively, it is equally possible that triggering CD95 on nonparenchymal cells initiates the release of a variety of secondary hepatocytotoxic mediators including TNF.
To determine whether CD95-induced hepatocyte apoptosis has a causal role in liver failure, the temporal sequence of events leading to liver cell lysis was determined. In addition, we compared the effect of the transcriptional inhibitor D-galactosamine (GalN) on TNF-or anti-CD95-induced hepatocytotoxicity in primary liver cell cultures and in mice. In order to test the existence of a functional relationship or cooperation between the TNF and the CD95 pathways, we used primary murine hepatocyte cultures from mouse strains deficient in TNF-R1 (45) or CD95. These cultures were challenged with either agonistic anti-CD95 Ab or with TNF. In addition to these in vitro experiments, we used three different models of in vivo hepatic failure in order to compare anti-CD95 or TNF effects in mice deficient for expression of either TNF-R1 or functional CD95.
MATERIALS AND METHODS

Materials
Recombinant TNF-a was generously provided by Dr. G. R. Adolf, Bender & Co. (Vienna, Austria) and rhuIL-l13 was from Ciba Geigy (Basel, Switzerland). D-galactosamine was purchased from Roth Chemicals (Karlsruhe, Germany). Salmonella abortus equi endotoxin (LPS) was purchased from Sebak (Aidenbach, Germany). The n x 123 bp molecular weight marker was from Gibco (Eggenstein, Germany). An IgG fraction of ovine anti-murine TNF-a antiserum was prepared as described (8) . The agonistic anti-CD95 antibody (22) Jo-2 was from Pharmingen (Hamburg, Germany). Unless further specified, all other reagents were purchased from Sigma (Deisenhofen, Germany).
Animals
Specific pathogen-free male BALB/c or C57BL/6 mice (25 g) were from the internal animal breeding house, University of Konstanz. A breeding stock of 55-kD TNF-R (CD121a)-deficient mice (45) (48) was determined in culture supernatants (S), and in the remaining cell monolayer (C) after lysis with 0.1% Triton X-100. The percentage of lactate dehydrogenase release was calculated from the ratio of S/(S + C). Alternatively, the capacity to produce formazan from MTT was measured according to the method of Mosmann (49) essentially as described recently (8) . Routinely, cytotoxicity was measured in parallel assays using lactate dehydrogenase (LDH) release and MTT reduction as readouts. The correlation of the two methods was 97%. In Results below only one representative set of data from either method is presented. Hepatocytolysis in vivo was determined by measuring the plasma activities of ALT, aspartateaminotransferase, and sorbitol dehydrogenase (48) . DNA fragmentation in hepatocyte cultures or in murine livers was quantitated by measuring cytosolic oligonucleosome-bound DNA using an ELISA-kit (Boehringer, Mannheim, Germany) as described (8) . As CD95 stimulation was apoptotic, as determined by morphological criteria. The time course for LDH release, formation of nuclei with condensed chromatin, and DNA fragmentation in hepatocyte cultures exposed to anti-CD95 revealed that apoptosis and oligonucleosomal DNA cleavage occurred before loss of membrane integrity. The onset of DNA fragmentation in the presence of anti-CD95 was more rapid than in TNF-challenged cells and clearly preceded cell lysis. These findings suggested that agonist binding to CD95 on hepatocytes is sufficient to directly cause apoptosis in this cell type.
Next, the concentration-dependence of CD95-mediated hepatocyte killing and its modulation by various culture conditions were examined (Fig. 2) . The presence of transcriptional inhibitors such as GalN or ActD significantly increased the extent of cell damage caused by anti-CD95 without causing a significant shift of the concentration response curve to the left. Simultaneous administration of TNF and anti-CD95 to hepatocyte cultures sensitized with ActD caused additive toxicity rather than a synergistic effect ( Fig. 2 B and D) . The median cytotoxic concentration (LC50) of anti-CD95 was in the range of [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] ng/ml, irrespective of the amount of TNF-a present. Varying between individual cell preparations, maximum toxicity was obtained using 50-300 ng/ml anti-CD95.
The difference in sensitivity to the enhanced toxicity caused by transcriptional inhibitors (i.e., more than 1000-fold sensitization for TNF compared with a maximum 2-fold sensitization for anti-CD95) suggests that different intracellular mechanisms are involved in the initiation of cell death by CD95 stimulation and by TNF-R1 activation. This notion is further substantiated by the finding that the two pathways leading to hepatocytotoxicity were differentially influenced by the oxygen tension to which the cells were exposed ( Fig. 2 A and C anti-CD95 (ng/ml) A 7500 C however, to be sensitive to incubation with a combination of TNF and ActD. There was no significant difference in the sensitivity towards TNF-induced killing over a large range of concentrations for cell preparations derh-L-iU from either wt or lpr mice (Fig. 3B) . In addition, cytosolic DNA extracted from ActD/TNF-treated hepatocytes derived from either substrain showed a typical DNA ladder pattern suggestive of apoptotic DNA fragmentation (Fig. 3C) Hepatocytes isolated from these mice allowed us to study the independent effects of CD95 activation on programmed cell death in hepatocytes. We first checked whether TNF would modify anti-CD95 toxicity in nonsensitized hepatocytes from wt C57B1/6 mice. Different concentrations of anti-CD95 induced cell death to different levels, which were, however, not influenced by the presence of TNF over a wide range of concentration (Fig. 5A) . The concentration-response curve of anti-CD95 in hepatocytes from wt mice was similar to that in cells from tnf-rlo mice. In addition, the toxicity of anti-CD95 was influenced neither by the presence of high concentrations of TNF nor by the simultaneous addition of neutralizing anti-TNF antibodies (Fig. 5B) . Finally, we studied anti-CD95 toxicity in hepatocytes from both substrains when transcriptional inhibitors were present. As described previously (8), ActD alone had a higher basal toxicity in wt hepatocytes as compared to tnf-rlo cells. This could be due to endogenously released TNF, since this basal toxicity was reduced by cotreatment with neutralizing anti-TNF antibodies. Although the maximum damage induced by anti-CD95 was similar in wt and tnf-rlo hepatocytes with or without transcriptional inhibitors, a small but consistent difference in sensitivity to toxicity was observed (Fig. SC) . wt hepatocytes exhibited a seemingly 2-fold lower LC50 to anti-CD95 when sensitized with ActD or GalN. This may be due to a different basal viability and therefore a higher susceptibility to damage by additional stimuli of these cells, which are highly sensitive even to trace concentrations of TNF, rather than due to a direct interaction of anti-CD95 with TNF-R1.
In order to verify the apoptotic nature of CD95-induced cell death in tnf-rlo-deficient hepatocytes, we measured DNA fragmentation 6 hr after incubation with anti-CD95, at a time when no significant cell lysis had occurred. We observed typical oligonucleosomal DNA-fragmentation in both wt and tnf-rl°hepatocytes (Table 1) . Taken together, these data suggest that neither is TNF-R1 activation required as a costimulatory signal nor is it directly involved in CD95-induced hepatocyte apoptosis. appearance of apoptosis preceded hepatocyte lysis. We thus determined whether this was also true following challenge of mice with anti-CD95. Time course analysis of DNA fragmentation and ALT release (a parameter of cell lysis) showed that in the CD95 model there also was an early increase of DNA fragmentation followed later by cell lysis (Fig. 6A) . Fragmented DNA was confirmed to consist of the typical oligonucleosomal pattern by agarose gel electrophoresis (Fig. 6B) . In this respect, the findings are similar to the TNF-dependent model, however no sensitization by transcriptional block was required and passive immunization of mice against TNF did not modify the toxicity of anti-CD95 in vivo (data not shown).
CD95-Induced
In order to confirm the in vitro findings obtained using tnf-rl°hepatocytes, the sensitivities of wt and tnf-rl°mice to CD95 activation and to the TNF-inducing inflammogen Con A were determined. Con A injection (25 mg/kg) caused systemic TNF release (wt: 187 ± 34 pg/ml; tnf-rl°: 328 ± 160 pg/ml) in both mouse substrains. Significant (p < 0.05, n = 7) hepatotoxicity was, however, only induced in wt mice (ALT: 1853 ± 856 U/1), whereas tnf-rl°mice were not affected (ALT: 99 ± 22U/1). In contrast, following challenge with anti-CD95 there were no significant differences between the two substrains with respect to time course and to the extent of DNA fragmentation and cell lysis (Fig. 7A) . In addition, histological examination showed that early hepatocyte apoptosis was present in livers from either mouse substrain (Fig. 7 B and C) . Only 5 hr after anti-CD95 injection, there was a massive increase in DNAcontaining intracellular and extracellular apoptotic bodies and hyperchromatic marginated chromatin in hepatocyte nuclei (20% of all hepatocytes). These histological signs of apoptosis were even more pronounced than those found after TNF injection into GalN-sensitized wt mice (41) . There was no significant infiltration of leukocytes, but a strong intra-and extra-sinusoidal accumulation of erythrocytes. These results are consistent with the in vitro experiments described above and in agreement with the data published by Ogasawara et al. (22) . The findings strongly suggest that CD95 activation or TNF-R1 stimulation represent two independent pathways resulting in liver cell apoptosis.
Different Modulation of Anti-CD95-induced Liver Injury
Compared with That Observed in TNF-Dependent Models The induction of anti-CD95-induced hepatotoxicity did not require pretreatment of mice with ActD or GalN. However, as shown in Fig. 8 animals from each substrain were terminally anesthesized. Blood was withdrawn into heparinized syringes for the determination of ALT and sorbitol dehydrogenase (SDH), and livers were excised for the determination of DNA fragmentation. Three untreated control mice were killed after the same time periods as a control for hepatic DNA fragmentation. They administered simultaneously. This is in strong contrast to the 1,000-to 10,000-fold sensitization by GalN observed in the TNF-mediated models. This lack of sensitization by GalN is also a strong argument against a possible endotoxin contamination of the anti-CD95 preparation as a cause for its hepatotoxicity. Such contamination is a major problem in investigations of inflammogens in vivo, since even trace amounts of endotoxin strongly enhance TNF toxicity. We therefore addressed this problem by comparing the hepatotoxicity of anti-CD95 in LPS-sensitive C3H/HeN and LPS-resistant C3H/HeJ mice. We found no significant difference between the sensitivity of these two strains to anti-CD95 (Table 2) . and anti-CD95 injection did not cause systemic TNF release.
Finally, we examined whether pre-treatment of mice with IL-1, which is known to pre- death. Second, sensitization of cells was not a prerequisite for killing by anti-CD95, while it was a necessary metabolic condition for TNFinduced hepatocyte apoptosis (21) . Preincubation of hepatocytes with ActD had a significant influence neither on the concentration dependency nor on the time course of anti-CD95-induced cell lysis or DNA fragmentation. The only parameter affected by ActD was the relative size of the population of hepatocytes killed by anti-CD95 treatment, since the maximum obtainable cytotoxicity was increased from 60-70% in cell cultures stimulated with anti-CD95 only to 80-95% in cells incubated with anti-CD95 plus ActD. Third, anti-CD95-and TNF-induced hepatocyte apoptosis were modulated differently by the ambient oxygen concentration. Switching oxygen partial pressure from 400 to 200 hPa reduced TNF toxicity, but did not influence anti-CD95 toxicity. From these observations, we conclude that the nature of the mechanisms that finally result in cell death of anti-CD95-or TNFchallenged hepatocytes is different. In addition to the characterization of the types and modalities of cell death due to TNF-R1 or CD95 stimulation, the hepatocyte culture system was used for the examination of putative interactions of TNF-R1 and CD95. For this purpose, we used hepatocytes from wt mice stimulated with a combination of TNF and anti-CD95 and hepatocytes from mice lacking either TNF-R1 or functional CD95. Although it has been noted before that lpr mice are protected against anti-CD95 toxicity (22) , it has also been shown that CD95 expression in these mice may not be completely absent (51) . We demonstrated that liver cells derived from such mice are completely resistant towards agonist stimulation of CD95, even after sensitization with ActD. We therefore assume that in lpr mice CD95 expression is either absent or does not exert its normal function in liver tissue. Using these lpr mice, we showed that TNF toxicity is not modulated by CD95. In a complementary experiment, utilizing hepatocyte cultures from tnf-rl°mice, we found that anti-CD95 toxicity is not modulated by TNF-R1. In an additional set of experiments, we investigated whether stimulation of either one of the two cell death transmitting receptors may influence the toxicity due to stimulation of the other. We did not find any evidence for this and concluded that stimulation of either anti-CD95 or TNF-R1 in hepatocytes represents one of two independent pathways for inducing apoptosis.
The key findings in our in vitro experiments were subsequently shown to also apply to the in vivo situation. As hepatic DNA fragmentation was caused by anti-CD95 or TNF stimulation of hepatocytes in vivo and in vitro, and DNA cleavage preceded cell lysis and subsequent liver failure in both models, it was concluded that hepatocyte apoptosis is an early pathological event that is causally involved in subsequent fulminant liver failure. By utilizing lpr and tnfr-1°mutant mice with different genetic backgrounds, we were able to show in three different experimental models of inflammation (generated by injection of Con A and anti-CD95 in nonsensitized mice and by TNF injection in ActD-sensitized mice) that CD95 and TNF-R1 cause hepatic failure independently of each other.
Two independent pathways regulating hepatocyte apoptosis via the stimulation of two different members of the TNF-R/nerve growth factor receptor family seem to exist (Fig. 9) The common link between the T cell-dependent models, such as using Con A as a polyclonal stimulator, and models involving macrophage activation by immunostimulants such as LPS, is the systemic release and the distal toxic action of TNF. The role of CD95L in these models is poorly characterized. It has, however, been shown by experimental intervention using either neutralizing anti-TNF antibodies or by deletion of TNF-Rl that hepatotoxicity in these models is explained by the activation of the TNF pathway alone (8, 35, 38, 45, (52) (53) (54) . It remains to be established whether "the CD95 death factor" (3) represents an additional or alternative mechanism of liver dysfunction during a complex event such as shock. Based on the present experimental knowledge, several possibilities for the pathophysiological role of the CD95 system may be envisaged ( Fig. 9) : (i) Hepatocytes may be killed by soluble systemic CD95L. For instance an increased release of this CD95 agonist from lymphocytes has been shown during infection with human immunodeficiency virus (HIV) or following incubation with the HIV-encoded tat protein (55) . (ii) Hepatocytes may be killed by cell surface CD95L on T cells (56) . Since CD95 expression has been associated with human viral hepatitis and fulminant liver failure (43, 44) , this may represent an endogenous mechanism for the control of viral infection in the liver. ( iii) The CD95 pathway may be involved in the control of adaptational liver growth and homeostasis together with TGF-f3 (57) and the activin system (58) . Although purely hypothetical, the constitutive presence of functional CD95 on hepatocytes makes such a role of the CD95 receptor ligand system feasible.
TNF and other products from liver nonparenchymal cells have been associated with many different liver diseases and liver toxicity (59, 60) . The reticuloendothelial system of the liver and especially TNF have been suggested to be involved in liver failure due to xenograft rejection (61), alcohol-induced liver disease (62), viral infection (63) , and chemical insult (64) (65) (66) (67) (68) . The role of CD95, which we have shown to be a potent inducer of apoptosis in nonsensitized hepatocytes in vivo or in vitro, has not been evaluated in this large variety of liver disorders. Since the CD95 system acts independently from TNF and its receptors on hepatocytes, and the activation of the CD95 death pathway seems to follow mechanisms different from those of the TNF system, further investigation of the individual roles of these two apoptosis-mediating systems in liver pathogenesis is warranted.
